Eledon Pharmaceuticals amends 8-K to correct auditor dismissal period; Crowe served only FY 2024

Eledon Pharmaceuticals, Inc.

Corrects prior 8-K that inadvertently referenced Crowe LLP for fiscal year 2023.
Audit Committee dismissed Crowe LLP and engaged Deloitte & Touche LLP on April 1, 2025.
Crowe served as auditor from July 10, 2024 to April 1, 2025; no disagreements or reportable events.
Deloitte engaged as independent auditor for fiscal year ending December 31, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.